Literature DB >> 11553541

Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection.

S Alonso1, K Pethe, N Mielcarek, D Raze, C Locht.   

Abstract

Pertussis toxin (PT) and filamentous hemagglutinin (FHA) are two major virulence factors of Bordetella pertussis. FHA is the main adhesin, whereas PT is a toxin with an A-B structure, in which the A protomer expresses ADP-ribosyltransferase activity and the B moiety is responsible for binding to the target cells. Here, we show redundancy of FHA and PT during infection. Whereas PT-deficient and FHA-deficient mutants colonized the mouse respiratory tract nearly as efficiently as did the isogenic parent strain, a mutant deficient for both factors colonized substantially less well. This was not due to redundant functions of PT and FHA as adhesins, since in vitro studies of epithelial cells and macrophages indicated that FHA, but not PT, acts as an adhesin. An FHA-deficient B. pertussis strain producing enzymatically inactive PT colonized as poorly as did the FHA-deficient, PT-deficient strain, indicating that the ADP-ribosyltransferase activity of PT is required for redundancy with FHA. Only strains producing active PT induced a local transient release of tumor necrosis factor alpha (TNF-alpha), suggesting that the pharmacological effects of PT are the basis of the redundancy with FHA, through the release of TNF-alpha. This may lead to damage of the pulmonary epithelium, allowing the bacteria to colonize even in the absence of FHA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553541      PMCID: PMC98732          DOI: 10.1128/IAI.69.10.6038-6043.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Filamentous hemagglutinin of Bordetella pertussis. A bacterial adhesin formed as a 50-nm monomeric rigid rod based on a 19-residue repeat motif rich in beta strands and turns.

Authors:  A M Makhov; J H Hannah; M J Brennan; B L Trus; E Kocsis; J F Conway; P T Wingfield; M N Simon; A C Steven
Journal:  J Mol Biol       Date:  1994-08-05       Impact factor: 5.469

2.  Pertussis toxin activates protein kinase C and a tyrosine protein kinase in the human T cell line Jurkat.

Authors:  R E Thom; J E Casnellie
Journal:  FEBS Lett       Date:  1989-02-13       Impact factor: 4.124

3.  Pertussis toxin triggers rapid second messenger production in human T lymphocytes.

Authors:  P M Rosoff; R Walker; L Winberry
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

4.  Leucocytosis-promoting factor of Bordetella pertussis. I. Purification and characterization.

Authors:  Y Sato; H Arai
Journal:  Infect Immun       Date:  1972-12       Impact factor: 3.441

5.  Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.

Authors:  A A Weiss; E L Hewlett; G A Myers; S Falkow
Journal:  J Infect Dis       Date:  1984-08       Impact factor: 5.226

6.  Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia.

Authors:  E Tuomanen; A Weiss; R Rich; F Zak; O Zak
Journal:  Dev Biol Stand       Date:  1985

7.  Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells.

Authors:  E Tuomanen; A Weiss
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

Review 8.  Molecular aspects of Bordetella pertussis pathogenesis.

Authors:  C Locht
Journal:  Int Microbiol       Date:  1999-09       Impact factor: 2.479

9.  Adaptive responses of human monocytes infected by bordetella pertussis: the role of adenylate cyclase hemolysin.

Authors:  E Njamkepo; F Pinot; D François; N Guiso; B S Polla; M Bachelet
Journal:  J Cell Physiol       Date:  2000-04       Impact factor: 6.384

10.  Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells.

Authors:  E Tuomanen; H Towbin; G Rosenfelder; D Braun; G Larson; G C Hansson; R Hill
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  21 in total

1.  Overrepresentation of a gene family encoding extracytoplasmic solute receptors in Bordetella.

Authors:  Rudy Antoine; Françoise Jacob-Dubuisson; Hervé Drobecq; Eve Willery; Sarah Lesjean; Camille Locht
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

2.  Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.

Authors:  Nicholas H Carbonetti; Galina V Artamonova; Charlotte Andreasen; Edward Dudley; R Michael Mays; Zoe E V Worthington
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

3.  Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development.

Authors:  Zhang Jinyong; Zhang Xiaoli; Zhang Weijun; Guo Ying; Guo Gang; Mao Xuhu; Zou Quanming
Journal:  Mol Biol Rep       Date:  2010-09-28       Impact factor: 2.316

Review 4.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

5.  Bordetella filamentous hemagglutinin plays a critical role in immunomodulation, suggesting a mechanism for host specificity.

Authors:  Carol S Inatsuka; Steven M Julio; Peggy A Cotter
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-09       Impact factor: 11.205

6.  Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates.

Authors:  Si Ying Ho; Shi Qian Chua; Damian G W Foo; Camille Locht; Vincent T Chow; Chit Laa Poh; Sylvie Alonso
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

7.  Pertussis toxin plays an early role in respiratory tract colonization by Bordetella pertussis.

Authors:  Nicholas H Carbonetti; Galina V Artamonova; R Michael Mays; Zoe E V Worthington
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Monocyte-derived interleukin-10 depresses the Bordetella pertussis- specific gamma interferon response in vaccinated infants.

Authors:  V Dirix; V Verscheure; T Goetghebuer; M Hainaut; A S Debrie; C Locht; F Mascart
Journal:  Clin Vaccine Immunol       Date:  2009-10-21

9.  Natural-host animal models indicate functional interchangeability between the filamentous haemagglutinins of Bordetella pertussis and Bordetella bronchiseptica and reveal a role for the mature C-terminal domain, but not the RGD motif, during infection.

Authors:  Steven M Julio; Carol S Inatsuka; Joseph Mazar; Christine Dieterich; David A Relman; Peggy A Cotter
Journal:  Mol Microbiol       Date:  2009-02-10       Impact factor: 3.501

Review 10.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.